May 13: The Week in Cancer News
First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.
Progress Against Cancer
First child to receive CAR T-cell therapy celebrates 10 years cancer-free, and authorization denials delay treatment for patients with Medicare Advantage.
The 10-year survival beginning five years after diagnosis IS seen as about 10 percent lower than in age-matched general population, a gap that persists for many years, The study reports. People who were treated...
Adolescents and young adult cancer survivors at higher risk for dying from a new cancer diagnosis, and FDA grants full approval to Enhertu for metastatic HER2-postive breast cancer.
The FDA has granted full approval to an antibody-drug conjugate for certain patients with breast cancer. The U.S. Food and Drug Administration (FDA) has approved fam-trastuzumab deruxtecan-nxki (Enhertu) for the treatment of certain adult...
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
FDA proposes ban on menthol cigarettes, and other stories from the week in cancer news.
Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.
A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More